Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Peter Impey

- PMLiVE

Sanofi and Regeneron share positive late-stage results for Dupixent in COPD

About 300,000 people in the US have uncontrolled COPD and evidence of type 2 inflammation

- PMLiVE

Why healthcare and pharma businesses need video marketing

Video has become such a major part of our online experiences that omnichannel marketing can’t really happen without it. And that goes for every industry, including health and pharma.  YouTube...

Wallace Health

- PMLiVE

Chasing the alchemy of trial diversity with a mix of culture change and practical mechanics

Industry needs to follow functional realignment to empower a culture change

- PMLiVE

PUTTING RARE DISEASE UNDER THE MICROSCOPE: WHY A DEEPER UNDERSTANDING OF GENETICS COUNTS

Our genetic makeup has a significant role in health and disease. In this blog, we will explore how well we understand the genetic components of rare disease, and what is...

IGNIFI

- PMLiVE

How social media is censoring women’s health content

At Wallace Health we’re passionate about the power of content and how it can change behaviour and improve lives. Along with our clients, we understand the value and the need...

Wallace Health

- PMLiVE

Medscape Brings Impact and Data to ESPGHAN

The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...

Medscape Education Global

- PMLiVE

Amgen’s Imdelltra granted FDA accelerated approval to treat small cell lung cancer

More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year

- PMLiVE

Eli Lilly shares promising phase 3 results for once-weekly insulin efsitora in type 2 diabetes

It is hoped that a once-weekly treatment option could lead to improved adherence

- PMLiVE

Sanofi and Sobi’s Altuviiio label updated by FDA with expanded paediatric data in haemophilia A

The therapy’s weekly dosing has a half-life of up to four times longer than current factor VIII therapies

- PMLiVE

Women in pharma

Iona Everson from PMGroup spoke to Ioana Parsons, general manager of Ipsen UK and Ireland, about her career path and her experiences working in pharma

- PMLiVE

Empowering Nurses Through Education

Nurse education is powerful and makes an impact.

Medscape Education Global

- PMLiVE

Johnson & Johnson to expand dermatology portfolio with $850m Proteologix acquisition

The company will gain access to two treatments for atopic dermatitis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links